U.S. Markets closed

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
121.02+2.02 (+1.70%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts18181818
Avg. Estimate3.52-1.05-0.51-6.32
Low Estimate-1.61-1.79-6.75-9.42
High Estimate10.437.395.93-2.31
Year Ago EPS-1.3-1.32-5.29-0.51
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts15151618
Avg. Estimate420.92M61.05M465.43M55.76M
Low EstimateN/AN/AN/AN/A
High Estimate900.87M900M917.04M261.3M
Year Ago Sales18.12M148k719k465.43M
Sales Growth (year/est)2,223.00%41,150.00%64,633.00%-88.00%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.95-1.18-1.27-1.47
EPS Actual-1.3-1.32-1.5-1.51
Difference-0.35-0.14-0.23-0.04
Surprise %-36.80%-11.90%-18.10%-2.70%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate3.52-1.05-0.51-6.32
7 Days Ago3.52-1.05-0.51-6.32
30 Days Ago3.26-1.08-0.82-6.29
60 Days Ago1.51-1.08-2.61-6.36
90 Days Ago-1.53-1.56-6.08-6.41
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCRSPIndustrySector(s)S&P 500
Current Qtr.370.80%N/AN/AN/A
Next Qtr.20.50%N/AN/AN/A
Current Year90.40%N/AN/AN/A
Next Year-1,139.20%N/AN/AN/A
Next 5 Years (per annum)-200.40%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A